Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Two RSV vaccines were approved for use in Australia last year by the Therapeutic Goods Administration. The Australian Government is funding Pfizer’s Abrysvo for pregnant women and, in an unusual ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

When sick, it will be best to stay home, isolate and stay away from others. The US CDC recommends the RSV vaccine for all adults aged 75 and older, as well as for adults aged 60 to 74 who are at ...

The policy was reversed in 2023, when a new RSV vaccine for infants was introduced. Halifax pediatric infectious disease physician Joanne Langley said the study shows why it's crucial to examine the ...

Up until 2016, babies in Nova Scotia born at 32 weeks gestation or less were eligible for palivizumab, a vaccine administered in four or five doses in an RSV season. But that year, the IWK ...

Marc Watkins, M.D., chief medical officer at Kroger Health, discusses RSV and how people can protect themselves and their ...

P.E.I.’s Chief Public Health Officer is working towards expanding eligibility for RSV vaccines as the province experiences high levels of respiratory illnesses this season.